Recurrent Visual Pathway Glioma
2 clinical trials · Condition
◉ Watch Recurrent Visual Pathway Glioma
| Record | Firm | Date |
|---|---|---|
| Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors (NCT02780804) | National Cancer Institute (NCI) | 2017-01-06 |
| Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma (NCT01089101) | National Cancer Institute (NCI) | 2010-07-07 |
Track Recurrent Visual Pathway Glioma automatically
Every clearance here is in the API, with alerts when new ones post.